Examining the Characteristics of Colchicine-Induced Myelosuppression in Clinical Cases: A Systematic Review.

Bernice L Sim Beatrice Z Sim Matthew J Tunbridge David F L Liew Philip C Robinson

Published in: The Journal of rheumatology (2022)

Colchicine has few reports of myelosuppression. The majority of patients with myelosuppression had preexisting renal impairment or concomitant CYP3A4 or P-gp inhibitor use. Caution should be taken in this subset of patients with increased monitoring.

Keyphrases

high glucose
diabetic rats
drug induced
adverse drug